One can stay invested in LLY stock as it still has growth prospects despite disappointing sales of Mounjaro and Zepbound in ...
Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...
With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...
A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...
While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...
About Eli Lilly and Company, Merck & Co. and Inc. Eli Lilly and Company ... and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, ...
Bayer has acquired full rights to two drugs partnered with Loxo Oncology, on the same day that the biotech was taken over by Eli Lilly in an $ ... is in phase I/II testing as a rescue therapy ...
Drugmaker Lupin aims to be part of the first wave of generic drugmakers to make GLP-1 receptor agonists products, used to ...
The CVU girls soccer team won its 20th state championship in program history this fall and the Redhawks had four players make ...
Montpelier senior Clayton Foster was named Player of the Year, while all 11 Harwood starters collected All-League honors when the Capital Division boys soccer coaches announced their 2024 postseason ...